ABCG2 and brain neoplasm: Melatonin reduces the expression of transport proteins and the resistance of brain tumor stem cells to chemotherapy drugs by inducing methylation of the promoter of ABCG2/BCRP, a member of the adenosine triphosphate-binding box (ABC) superfamily (Martín et al., 2013).